DOMICILIUM REAL ESTATE FUND III LP enters ELOXX PHARMACEUTICALS, INC. with 1.41M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Indirect Derivatives
Filed: 5/4/2026ACC: 0000919574-26-002621
10% Owner
Since Apr 2026
1.41M
Baseline shares
0.00
Direct ownership
0 positions
22.21M
Derivative underlying
2 instruments
2
Security positions
1.41M indirect
Non-Derivative Holdings2
Common Stock, $0.01 par value
IndirectShares owned157.14K
Common Stock, $0.01 par value
IndirectShares owned1.25M
Total
1.41M indirect1.41M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock, $0.01 par value | 157.14K | Indirect |
| Common Stock, $0.01 par value | 1.25M | Indirect |
| Total | 1.41M | 1.41M indirect |
Derivative Holdings2
Pre-funded Warrant
IndirectUnderlying security
Common Stock, $0.01 par value
Underlying shares
1.37M
Shares owned
N/A
Exercise price
0.01
Expiration
—
Exercise window
—
Pre-funded Warrant
IndirectUnderlying security
Common Stock, $0.01 par value
Underlying shares
20.84M
Shares owned
N/A
Exercise price
0.01
Expiration
—
Exercise window
—
Total
Underlying
22.21M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Pre-funded Warrant Indirect | Common Stock, $0.01 par value | 0.01 | — | — | 1.37M | N/A |
| Pre-funded Warrant Indirect | Common Stock, $0.01 par value | 0.01 | — | — | 20.84M | N/A |
| Total | 22.21M | 0.00 | ||||